ClinicalTrials.Veeva

Menu

Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy

University Health Network, Toronto logo

University Health Network, Toronto

Status and phase

Terminated
Phase 2

Conditions

Partial Nephrectomy
Renal Cell Carcinoma

Treatments

Procedure: Hypoperfusion of renal artery

Study type

Interventional

Funder types

Other

Identifiers

NCT01720693
Hypoperfusion

Details and patient eligibility

About

Many patients who are candidates for nephron-sparing surgery, partial nephrectomy is now the standard treatment with a surgical, small, clinical T1 tumor (<7 cm). In many recent studies, partial nephrectomy provides equivalent oncologic, and superior functional, outcomes compared with the standard radical nephrectomy over the short and long term (2, 3). Partial nephrectomy techniques, whether open, laparoscopic or robotic, typically involve hilar clamping, which creates the desired bloodless operative field, allowing for more precise tumor excision and renal reconstruction. This hilar clamping eventually may lead to ischemic kidney injury which can compromise the functional outcomes of the remaining kidney.We are working now to develop a novel technique of Hypo-Perfusion by achieving partial renal arterial clamping, with the goal of completely eliminating surgical ischemia to the renal remnant.

Enrollment

3 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient must be at least 18 years old scheduled for open partial nephrectomy

Exclusion criteria

  • No prior diagnosis of renal artery disease

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

3 participants in 1 patient group

hypoperfusion
Experimental group
Description:
Hypoperfusion of the renal artery
Treatment:
Procedure: Hypoperfusion of renal artery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems